KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads...

  1. Rich&Poor
    1,206 Posts.
    lightbulb Created with Sketch. 941
    clock Created with Sketch.
    25/11/20
    09:46
    Post #: 49122840
    The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling
    This is from tbone997 on the US Stockwits forum (tbone well done) excuse the pun.
    It is only a matter of time before Genentech buys back Paxalisib!

    June 2020 - International Journal of Molecular Sciences.
    Research from The European Cancer Stem Cell Research Institute, Cardiff University
    https://hotcopper.com.au/data/attachments/2680/2680546-16708eebdd6b88ad9c6d9a884c087c47.jpg

    file:///C:/Users/Owner/AppData/Local/Temp/The_PI3K-AKT-mTOR_pathway_and_prostate_cancer_At_t.pdf

    Regards
    KZA Price at posting: $1.37 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.